BioHarvest Sciences Inc. (BHST)

Market Cap	157.45M
Revenue (ttm)	32.72M
Net Income (ttm)	-11.89M
Shares Out	22.65M
EPS (ttm)	-0.68
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40,639
Open	7.12
Previous Close	6.83
Day's Range	6.81 - 7.20
52-Week Range	4.72 - 12.80
Beta	1.23
Analysts	Strong Buy
Price Target	13.00 (+87.05%)
Earnings Date	Nov 13, 2025

About BHST

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2007
• Employees: 2
• Stock Exchange: NASDAQ
• Ticker Symbol: BHST
• Website: https://www.bioharvest.com

Financial Performance

In 2024, BioHarvest Sciences's revenue was $25.19 million, an increase of 98.77% compared to the previous year's $12.67 million. Losses were -$12.91 million, 2.78% more than in 2023.

Analyst Summary

According to 2 analysts, the average rating for BHST stock is "Strong Buy." The 12-month stock price target is $13.0, which is an increase of 87.05% from the latest price.

Price Target

$13.0

(87.05% upside)

Analyst Consensus: Strong Buy